Bethyl Laboratories
Rabbit anti-CDK4 Recombinant Monoclonal Antibody [BLGR024]New
Primary
Catalog #A701-024
TargetCDK4
HostRabbit
CloneBLGR024
ReactivityHuman
ApplicationIHC
Image 1 of 1
local_shipping
This item has an estimated lead time of two weeks.
Product Description
Cyclin dependent kinase 4 (CDK4) is a member of the Ser/Thr protein kinase family. This protein is highly similar to the gene products of S. cerevisiae cdc28 and S. pombe cdc2. It is a catalytic subunit of the protein kinase complex that is important for cell cycle G1 phase progression. The activity of CDK4 is restricted to the G1-S phase, which is controlled by the regulatory subunits D-type cyclins and CDK inhibitor p16(INK4a). This kinase was shown to be responsible for the phosphorylation of retinoblastoma gene product (Rb). Mutations in the CDK4 gene as well as in its related proteins including D-type cyclins, p16(INK4a) and Rb were all found to be associated with tumorigenesis of a variety of cancers [taken from NCBI Entrez Gene (Gene ID: 1019)].
Specifications
Clonality
Recombinant Monoclonal
Clone
BLGR024
Host
Rabbit
Isotype
IgG
Reactivity
Human
Format
Whole IgG
Conjugate Type
Unconjugated
Purity
Purified
Target Identity
TargetCDK4
Antigen Species
Human
Gene ID1019
Gene Symbol
CDK4
Gene Name
cyclin dependent kinase 4
Uniprot IDP11802
Protein Name
Cyclin-dependent kinase 4
Alternate Names
Product Information
Applications
IHC
Buffer
Tris-buffered Saline with 1% BSA and <0.1% Sodium Azide
Storage Conditions
2 - 8 °C
Physical State
Liquid
Shelf Life
1 year from date of receipt
Country of Origin
USA
Applications
Immunohistochemistry (IHC)1:50 to 1:200
Documents
Product DatasheetPDF · A701-024 · Lot 1 (current lot)Open
Product DatasheetPDF · A701-024 · Lot 1 (current lot)Open
Safety Data SheetPDF · A701-024Open
Services
Antibody Conjugation
Antibody and conjugate formats developed together, built to your specification.
Request CustomizationCustom Monoclonal Antibody Discovery Services
Full custom monoclonal development, from immunization through validation.
Explore Monoclonal DevelopmentVHH Discovery
Single-domain antibodies for structurally difficult targets a conventional monoclonal can't reach.
Explore VHH DiscoveryResources
1



